כל המחקרים
גיוסPHASE2, PHASE3התערבותי

Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty

This research study is testing a new medicine called PLG0206. It's for people who have had a total knee replacement and have developed an infection in their new knee. When doctors treat these infections, they often perform a procedure called DAIR (Debridement, Antibiotics, and Implant Retention) to clean the joint and manage the infection. This study wants to find out if using PLG0206 as a rinse during the DAIR procedure can help stop the infection from coming back. Participants will either receive PLG0206 or a dummy treatment (placebo), along with their usual care. The study also checks how safe PLG0206 is. Everyone in the study will be watched closely for about a year after their procedure.

במבט חטוף

סטטוס
גיוס
שלב
PHASE2, PHASE3
נותן חסות
Peptilogics
יעד הרשמה
240
התחל
03 Feb 2026
השלמה משוערת
01 ספט 2028

על מה המחקר הזה?

Knee replacement surgery is a common operation that can greatly improve a person's quality of life. However, sometimes an infection can develop around the new joint, which is called a periprosthetic joint infection (PJI). This can be a serious problem and often requires further treatment.

One way doctors treat these infections is with a procedure called DAIR, which stands for Debridement, Antibiotics, and Implant Retention. This involves carefully cleaning the infected area and giving antibiotics, usually without removing the knee replacement itself. This study is exploring a new medicine, PLG0206, which might help prevent the infection from returning after a DAIR procedure. Researchers want to see if using PLG0206 as a rinse during the DAIR surgery, alongside standard care, can make a difference.

The main goal of this study is to see if PLG0206 can reduce the chances of the infection coming back in people who've had a knee replacement and are undergoing the DAIR procedure for a PJI. The study will also carefully check for any side effects or safety concerns related to using PLG0206. By taking part, you could help doctors understand better how to prevent these infections and improve outcomes for future patients.

נקודות עיקריות

  • This study investigates a new rinse, PLG0206, for knee replacement infections.
  • It aims to prevent infections from returning after a cleaning procedure (DAIR).
  • Participants will receive either PLG0206 or a dummy treatment (placebo).
  • The study also checks the safety of PLG0206.
  • Monitoring will last for approximately one year after surgery.
  • Your standard medical care for the infection will continue.

מי עשוי להיות זכאי?

To join this study, you need to be an adult between 18 and 80 years old. You must have an infection in your knee replacement (a PJI) that doctors believe can be treated with the DAIR procedure. Your knee replacement should be firmly in place, and the tissues around it should be in good condition. You also need to be able to understand the study, give your permission, and attend all the follow-up visits.

There are also some reasons why you might not be able to join. For example, if your knee replacement is loose or needs to be completely removed, or if your infection has spread beyond your knee. If you've had a history of knee infections in the same knee before, or if you have certain serious health conditions like uncontrolled diabetes or a weakened immune system, you might not be suitable. The study also cannot include you if you're expected to need antibiotics for more than six months after the DAIR procedure.

האם מחקר זה יכול להתאים לך?

ענה על השאלות המהירות הללו כדי לבדוק אם אתה עשוי להיות זכאי. זהו מדריך בלבד — צוות המחקר מקבל את ההחלטה הסופית.

  1. האם אתה בין גיל 18 ל-80?
  2. Do you have an infection in your total knee replacement?
  3. Is your knee replacement firmly in place and the surrounding tissue healthy?
  4. Has your doctor said the DAIR procedure is suitable for your infection?
  5. Are you able to attend follow-up appointments for about a year?
ענה על כל שאלה כדי לראות את התוצאה שלך.

מה כרוך בהשתתפות?

If you join this study, you will undergo the DAIR procedure for your knee infection, just as your hospital normally performs it. During this surgery, after cleaning, you'll receive either PLG0206 or a matching dummy solution (placebo) as a rinse within your knee joint. You won't know which one you receive, and neither will your doctor, to ensure fair results. Following the procedure, you'll get your standard post-operative care, which may include antibiotics.

After leaving the hospital, you'll be monitored for approximately one year (365 days). This involves several follow-up visits: in-person visits at 14, 90, and 365 days after your treatment, and phone or video calls at 30, 180, and 270 days. During these visits, doctors will check your safety and look for any signs that your knee infection has returned or hasn't fully cleared up. The whole study monitoring period lasts for one year from the day you have your DAIR procedure.

סיכונים ותועלות פוטנציאליים

Potential benefits of taking part include contributing to medical research that could help improve treatments for prosthetic joint infections in the future. While there's no guarantee the study drug will directly benefit you, you might receive a treatment that proves to be effective. As with any medical procedure or medication, there are potential risks, including side effects from the study drug or complications related to your surgery and recovery. The research team will explain all known risks. Remember, taking part in a clinical trial is always voluntary, and you have the right to withdraw from the study at any time, for any reason, without affecting your standard medical care.

מיקומים (21)

  • Clinical Trial Site
    מיקוד מאומת
    Sarasota, United States· גיוס
  • Clinical Trial Site
    מיקוד מאומת
    Tamarac, United States· גיוס
  • Clinical Trial Site
    מיקוד מאומת
    Shreveport, United States· גיוס
  • Clinical Trial Site
    מיקוד מאומת
    בולטימור, ארצות הברית· נמשך
  • Clinical Trial Site
    מיקוד מאומת
    בוסטון, ארצות הברית· גיוס
  • Clinical Trial Site
    מיקוד מאומת
    ניו יורק, ארצות הברית· נמשך
  • Clinical Trial Site
    מיקוד מאומת
    Leland, United States· גיוס
  • Clinical Trial Site
    מיקוד מאומת
    סינסינטי, ארצות הברית· גיוס
  • Clinical Trial Site
    מיקוד מאומת
    קליבלנד, ארצות הברית· גיוס
  • Clinical Trial Site
    מיקוד מאומת
    קולומבוס, ארצות הברית· גיוס
  • Clinical Trial Site
    מיקוד מאומת
    פיטסבורג, ארצות הברית· גיוס
  • Clinical Trial Site
    מיקוד מאומת
    דאלאס, ארצות הברית· גיוס

שאלות נפוצות

What is PLG0206?

PLG0206 is a new investigational medication being tested to see if it can help prevent knee replacement infections from coming back.

מהו 'פלצבו'?

A placebo is a dummy treatment that looks exactly like the study drug but contains no active medicine. It helps researchers fairly compare the new drug's effects.

כמה זמן אהיה במחקר?

You'll be monitored for about one year (365 days) after your knee cleaning procedure to check on your recovery and any return of infection.

האם אקבל עדיין את הטיפול הרגיל שלי?

Yes, all participants will receive the standard DAIR procedure and any other care your doctors usually recommend for your knee infection alongside the study treatment.

האם אני יכול לעזוב את המחקר בכל עת?

Absolutely. Your participation is completely voluntary, and you can withdraw from the study at any point without any impact on your ongoing medical care.

כיצד לגלות עוד

Peptilogics RETAIN Study Lead

תמיד התייעץ עם רופא המשפחה או המומחה שלך לפני שתחליט להשתתף במחקר.

מעוניינים להשתתף?

רשום את התעניינותך

שתף את הפרטים שלך וצוות המחקר עבור "Evaluation of PLG0206 in Prevention of Recurrent Infection i…" ייצרו איתך קשר אם אתה עשוי להיות זכאי. תמיד התייעץ עם הרופא שלך לפני שאתה מסכים להשתתף.

דיון

דיון קהילתי

מופעל על ידי הפורום שלנו ב community.patient.info. אנא היו מכבדים — זה אינו ייעוץ רפואי.